WHO adds to list of prequalified HIV medicines

Published: 7-Dec-2005

Two HIV/AIDS medicines have been added to the World Health Organization\'s (WHO) list of prequalified products. They are the antiretrovirals nevirapine, produced by Aurobindo, India, and lamivudine, produced by Aspen Pharmacare, South Africa.


Two HIV/AIDS medicines have been added to the World Health Organization's (WHO) list of prequalified products. They are the antiretrovirals nevirapine, produced by Aurobindo, India, and lamivudine, produced by Aspen Pharmacare, South Africa.

Aspen is the first African producer to be included on the list of WHO prequalified medicines with three other products listed in September the AIDS medicine Stavudine in three different strengths.

This brings to 70 the number of antiretrovirals prequalified by WHO, of which 36 are from generic manufacturers and 34 from brand name suppliers.

'Choices are expanding and the more choice there is, the more competitive the prices,' said Dr Hans Hogerzeil, in charge of Medicines Policy and Standards at WHO. 'We are confident that before the end of the year there will be additional inclusions to the prequalified products list.'

  

See more

You may also like

Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

Read more
The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
Pharmaceutical

Indian pharma firms develop niche portfolios

They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical

Indian generic manufacturers aim to enter the Japanese market

The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Media

Aurobindo's generic drug for osteoporosis approved by US FDA

The global osteoporosis drugs market is seeing significant growth due to a rising geriatric population and changing lifestyles
Finance

Aurobindo and Glenmark to get inflow of foreign capital

Deals underscore the importance given by the Indian government to strengthening healthcare in the country, by ensuring availability of drugs to the population at reasonable prices
Finance

Aurobindo divests stake in Australian subsidiary

Company also reaches settlement with Plethico over Natrol acquisition
Regulatory

Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis

The capsules were manufactured at two plants in India
Subscribe now